Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new Oxford Sparks animation travels inside our body, shrinking down to a cellular level, to see how amazing our immune system really is. The role of the immune system is to protect us against disease or invading threats, such as viruses, bacteria and parasites. But how does it do that?

The role of the immune system is to protect us against disease or invading threats, such as viruses, bacteria and parasites. But how does it do that?

When looking for new treatments for human disease, one possible strategy is to use observations made in the clinic and work back to the cellular causes. In the Davis and Cornall labs, we follow the opposite strategy - we  seek new treatments for human disease by first trying to understand how healthy cells function, focusing on the processes most likely to impact on disease.

As our video “The immune system - the battle within” shows, there is no process more interesting to investigate than the immune system (or at least we think so!). The immune system is the defence mechanism within our bodies - it normally protects us from foreign pathogens and other threats such as cancer but it is also the root cause of many debilitating diseases, such as diabetes and rheumatoid arthritis.

Watch the Oxford Sparks animation to find out more (Oxford Sparks website)

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.